Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
| ▸ | USP2 | O75604 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | EGFR | P00533 | 1/20 | 0.32 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | HTR6 | P50406 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3482992 | 0.86 | IDO1 (0.38) | IDO1MAPTTDP1L3MBTL1USP2 | |
| SCHEMBL250357 | 0.80 | KEAP1 (0.54) | L3MBTL1KDM4EHPGDHSD17B10KMT2A | |
| SCHEMBL6066253 | 0.79 | IDO1 (0.49) | IDO1MAPTKDM4EALDH1A1HPGD | |
| SCHEMBL1535641 | 0.76 | MEN1 (0.55) | MAPTTDP1L3MBTL1KDM4EALDH1A1 | |
| SCHEMBL7407714 | 0.76 | RXFP1 (0.51) | IDO1MAPTKDM4EALDH1A1POLB | |
| SCHEMBL11388125 | 0.75 | PABPC1 (0.46) | ALDH1A1PABPC1TSHR | |
| SCHEMBL11289604 | 0.73 | GAA (0.53) | IDO1MAPTKDM4EALDH1A1POLB | |
| SCHEMBL67474 | 0.73 | CYP1A2 (0.50) | MAPTKDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL9778189 | 0.71 | IDO1 (0.73) | IDO1MAPTTDP1L3MBTL1USP2 | |
| SCHEMBL30336868 | 0.71 | IDO1 (0.73) | IDO1MAPTTDP1L3MBTL1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2589631-B1 | INK COMPOSITION, INKJET RECORDING METHOD AND COLORED BODY | NIPPON KAYAKU KK (JP) | 2014-08-20 | — | — | EP | disclosed |
| US-8741046-B2 | Ink composition, inkjet recording method and colored body | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2014-06-03 | — | — | US | disclosed |
| EP-2589631-A1 | INK COMPOSITION, INKJET RECORDING METHOD AND COLORED BODY | Nippon Kayaku Kabushiki Kaisha (JP) | 2013-05-08 | — | — | EP | disclosed |
| US-20130101811-A1 | INK COMPOSITION, INKJET RECORDING METHOD AND COLORED BODY | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2013-04-25 | — | — | US | disclosed |
| US-7521454-B2 | Adenine derivatives | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2009-04-21 | — | — | US | disclosed |
| EP-1386923-B1 | NOVEL ADENINE DERIVATIVES | DAINIPPON SUMITOMO PHARMA CO (JP) | 2008-08-13 | — | — | EP | disclosed |
| US-20070037832-A1 | 2-butylamino-8-hydroxy-9-(6-methyl-3-pyridylmethyl)adenine; interferon inducing activity; antiviral, antiallergic agent; immune response modulator; hepatitis B and C, asthma, atopic dermatitis | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2007-02-15 | — | — | US | disclosed |
| US-7157465-B2 | Adenine derivatives | DAINIPPON SIMITOMO PHARMA CO., LTD. (JP) | 2007-01-02 | — | — | US | disclosed |
| CN-1250548-C | Novel adenine derivatives | SUMITOMO PHARMA (JP) | 2006-04-12 | — | — | CN | disclosed |
| CN-1512992-A | Novel adenine derivatives | ס����ҩ��ʽ���� | 2004-07-14 | — | — | CN | disclosed |
| US-20040132748-A1 | Novel adenne derivatives | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2004-07-08 | — | — | US | disclosed |
| EP-1386923-A1 | NOVEL ADENINE DERIVATIVES | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 2004-02-04 | — | — | EP | disclosed |
| EP-0304613-B1 | BENZOPYRAN DERIVATIVES | BASF Aktiengesellschaft (DE) | 1991-06-26 | — | — | EP | disclosed |
| US-4958021-A | PRESSURE AND HEAT SENSITIVE RECORDING MATERIALS | BASF AKTIENGESELLSCHAFT (DE) | 1990-09-18 | — | — | US | disclosed |
| EP-0304613-A1 | Benzopyran derivatives | BASF Aktiengesellschaft (DE) | 1989-03-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040132748-A1 | Novel adenne derivatives | IRF3, IFNAR1, STING1 | IDO1 13/4885MAPT 1548/4885TDP1 657/4885 |
| US-20070037832-A1 | 2-butylamino-8-hydroxy-9-(6-methyl-3-pyridylmethyl)adenine; interferon inducing activity; antiviral, antiallergic agent; immune response modulator; hepatitis B and C, asthma, atopic dermatitis | IRF3, IFNAR1, IFNG | IDO1 39/4885MAPT 859/4885TDP1 1546/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.